IMMUCELL CORP /DE/ 8-K

What Happened
ImmuCell Corporation announced unaudited financial results for the quarter ended March 31, 2026 in a press release and disclosed that release in a Form 8-K filed May 14, 2026. The press release (dated April 14, 2026) is attached as Exhibit 99.1 to the 8-K. The company states the information in the release is not being "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless explicitly stated.

Key Details

• 8-K filed: May 14, 2026; press release dated April 14, 2026.
• Period covered: quarter ended March 31, 2026 (unaudited financial results).
• Press release is attached as Exhibit 99.1 to the Form 8‑K.
• Company notes the release is not deemed “filed” under Section 18 and is not incorporated by reference into other securities filings.

Why It Matters
This 8-K signals that ImmuCell has released its quarterly earnings and other financial metrics that investors use to assess performance (earnings, revenue, cash position). Because the results are unaudited and presented in a press release, investors should review Exhibit 99.1 for the specific figures and any management commentary or guidance. The filing’s Section 18 disclaimer means the release is informational but is not intended to expand legal liabilities tied to formal filed disclosures.